BIOMAT Database Logo BIOMAT Database Logo

[Use of prodigiozan in complex treatment of endogenous infections]. 1980

G S Dvurechenskaia, and E A Markova, and E S Fortinskaia

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D011354 Prodigiozan A polysaccharide extracted from Serratia marcescens and other bacteria. It activates enzymatic activity of macrophages and stimulates phagocytic processes. Prodigiosan
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D018805 Sepsis Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. Bloodstream Infection,Pyaemia,Pyemia,Pyohemia,Blood Poisoning,Poisoning, Blood,Septicemia,Severe Sepsis,Blood Poisonings,Bloodstream Infections,Infection, Bloodstream,Poisonings, Blood,Pyaemias,Pyemias,Pyohemias,Sepsis, Severe,Septicemias

Related Publications

G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Use of lysozyme and prodigiozan in the treatment of suppurative infections in diabetics].
April 1984, Vestnik khirurgii imeni I. I. Grekova,
G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Use of prodigiozan in the complex therapy of dysentery].
April 1973, Vrachebnoe delo,
G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Use of prodigiozan in the complex therapy of burns].
January 1971, Antibiotiki,
G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Use of prodigiozan and tactivin for treatment of patients with chronic Klebsiella infections].
January 2001, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Complex treatment of late radiation injuries of the skin by use of prodigiozan].
October 1969, Antibiotiki,
G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Effectiveness of prodigiozan in the complex treatment of erysipelas].
August 1984, Klinicheskaia meditsina,
G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Use of prodigiozan in the complex therapy of acute pneumonia].
December 1970, Klinicheskaia meditsina,
G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Prodigiozan in the complex treatment of respiratory tract sarcoidosis].
September 1982, Klinicheskaia meditsina,
G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Experience with the use of prodigiozan in the complex treatment of patients with pulmonary tuberculosis].
October 1974, Antibiotiki,
G S Dvurechenskaia, and E A Markova, and E S Fortinskaia
[Protective effect of Prodigiozan in experimental infections].
August 1966, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!